Ultrasound Location of Misplaced Levonorgestrel Releasing Intrauterine System (LNG-IUS) - is it easy?
نویسندگان
چکیده
The Levonorgestrel intrauterine device (LNG-IUD) is a hormone-containing device licensed for treatment of menorrhagia and contraception. Though complications such as perforation have been reported similar to other non-hormonal intrauterine devices, the diagnosis of such complications is difficult with this device because the LNG-IUD has a different ultrasound appearance compared to copper devices and these case reports are intended to emphasize this point.
منابع مشابه
Failure to insert a levonorgestrel-releasing intrauterine system: a survey based on self-reports by Israeli gynecologists.
BACKGROUND The insertion of a levonorgestrel-releasing intrauterine system (LNG-IUS) requires experience and is associated with a low failure rate. OBJECTIVES To assess the reasons given by gynecologists why they failed to insert a LNG-IUS. METHODS We obtained data from the sole distributor in Israel that prospectively recorded these cases when contacted by gynecologists following an insert...
متن کاملManagement of a perforated levonorgestrel-medicated intrauterine device--a pharmacokinetic study: case report.
Intrauterine contraception is a widely used, highly effective method of birth control. Uterine perforation is a serious albeit rare complication with the use of an intrauterine device (IUD). Although uterine perforation by the levonorgestrel-releasing intrauterine system (LNG-IUS) has already been described, no plasma LNG concentrations in this setting were reported. Neither has the management ...
متن کاملNon-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Levonorgestrel releasing-intrauterine systems (LNG-IUS) were originally developed as a method of contraception in the mid 1970s. The only LNG-IUS approved for general public use is the Mirena LNG-IUS, which releases 20 mcg of levonorgestrel per day directly in to the uterine cavity. However, new lower dose (10 and 14 mcg per day) and smaller sized LNG-IUS (MLS, FibroPlant-LNG) are currently und...
متن کاملLevonorgestrel-releasing intrauterine system and new-onset acne.
We recently encountered 5 patients with new-onset acne after the placement of a levonorgestrel-releasing intrauterine system (LNG-IUS). The women ranged in age from 31 to 36 years and all developed inflammatory papules localized to the jawline and/or back 1 to 3 months after insertion of an LNG-IUS. None of the patients were aware that acne could be a side effect of the device. Therapy was init...
متن کاملFFPRHC Guidance (April 2004): The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health
Journal of Family Planning and Reproductive Health Care 2004: 30(2) What is the levonorgestrel-releasing intrauterine system? This Guidance provides recommendations and good practice points regarding the use of a levonorgestrelreleasing intrauterine system, the accepted abbreviation for which is LNG-IUS. The use of a copper-bearing intrauterine device (IUD) has been covered in previous Faculty ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Oman medical journal
دوره 24 1 شماره
صفحات -
تاریخ انتشار 2009